AstraZeneca Experiences Approval Delays
AstraZeneca Experiences Approval Delays. The release of asthma drug, Symbicort, is being delayed for approval to young children. Reuters said that regulators have asked Symbicort maker, AstraZeneca Plc, for additional [...]